Varian Medical Systems (VAR) Q2 2012 Earnings Call April 25, 2012 5:00 pm ET Executives Spencer R. Sias - Former Vice President of Corporate Communications & Investor Relations Timothy E. Guertin - Chief Executive Officer, President and Executive Director Elisha W. Finney - Chief Financial Officer and Corporate Executive Vice President of Finance Dow R. Wilson - Chief Operating Officer and Corporate Executive Vice President Analysts Jeremy Feffer - Cantor Fitzgerald & Co., Research Division Steve Beuchaw - Morgan Stanley, Research Division Amit Bhalla - Citigroup Inc, Research Division Anthony Petrone - Jefferies & Company, Inc., Research Division Sean D. Lavin - Lazard Capital Markets LLC, Research Division Tycho W. Peterson - JP Morgan Chase & Co, Research Division Dalton L. Chandler - Needham & Company, LLC, Research Division Jason Wittes - Caris & Company, Inc., Research Division Jeffrey D. Johnson - Robert W. Baird & Co. Incorporated, Research Division PresentationOperator
Good day, ladies and gentlemen, and welcome to the Second Quarter 2012 Varian Medical Systems Earnings Conference Call. My name is Anissia, and I will be your operator for today. [Operator Instructions] I would now like to turn the call over to Mr. Spencer Sias. Please proceed. Spencer R. Sias Thank you. Good afternoon, and welcome to Varian Medical Systems Conference Call for the Second Quarter of Fiscal Year 2012. Participating in this call are Tim Guertin, President and CEO; Elisha Finney, CFO; Dow Wilson, Executive Vice President and Chief Operating Officer; and Tai Chen, our Corporate Controller. Tim and Elisha will summarize our results, and we'll take your questions following the presentation.